Ieq Capital, LLC Hille Vax, Inc. Transaction History

Ieq Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.39 - $2.04 $5,229 - $7,674	-3,762 Reduced 18.61%	16,453 $32,000
Q1 2025 May 14, 2025	SELL	$1.45 - $2.14 $3,306 - $4,879	-2,280 Reduced 10.14%	20,215 $29,000
Q4 2024 Jan 31, 2025	BUY	$1.72 - $2.06 $16,071 - $19,248	9,344 Added 71.05%	22,495 $45,000
Q3 2024 Nov 14, 2024	BUY	$1.58 - $14.42 $20,778 - $189,637	13,151 New	13,151 $23,000

4.16M

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $69.9M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ieq Capital, LLC with notifications on news.